Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;150(3):186-192.
doi: 10.1016/j.adaj.2018.10.018.

Pharmacokinetics of 38% topical silver diamine fluoride in healthy adult volunteers

Pharmacokinetics of 38% topical silver diamine fluoride in healthy adult volunteers

Yvonne S Lin et al. J Am Dent Assoc. 2019 Mar.

Abstract

Background: Silver diamine fluoride (SDF) is used topically to prevent or arrest caries. The authors' aim was to characterize the kinetics of silver and fluoride after topical application of SDF.

Methods: Sixteen adults participated in a pharmacokinetics study after the application of 38% SDF to 5 teeth (approximately 50 microliters, estimated 4-11 milligrams per participant). Serum and urine samples were collected over 24 hours after application and were analyzed for silver and fluoride.

Results: Silver serum peak was 0.67 (standard deviation [SD], 0.49) nanograms per milliliter; median time to peak was 3 hours. The estimated elimination half-life of silver was 46 (SD, 26) hours. No silver was recovered in urine. Baseline fluoride serum levels ranged from less than 10 through 50 ng/mL (< 0.01-0.05 parts per million) and fluctuated around baseline after SDF. The 24-hour urinary fluoride was 1.29 (SD, 0.81) mg.

Conclusions: SDF was well tolerated in this study, and no adverse events related to SDF were reported.

Practical implications: This clinical study confirmed that topical application of 38% SDF, in growing use in the United States, is safe and well tolerated in healthy adults.

Keywords: Silver diamine fluoride; clinical study; dental; healthy volunteers.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests:

PM is a director of Advantage Silver Dental Arrest, LLC. The other authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Kinetics of silver following application of 38% silver diamine fluoride in healthy adults (n = 16). (A) Observed individual serum silver concentrations (open circles) with average serum silver concentrations (closed circles) and (B) baseline-corrected serum silver concentrations vs. time (average concentration ± standard deviation for each timepoint shown).
Figure 2.
Figure 2.
Kinetics of fluoride following application of 38% silver diamine fluoride in healthy adults (n = 16). (A) Mean observed serum fluoride concentrations vs. time (average concentration ± standard deviation for each timepoint shown). Limit of detection was 10 ng/mL (0.01 ppm) for serum fluoride.

Similar articles

Cited by

References

    1. Slayton RL, Urquhart O, Araujo MWB, et al. Evidence-based clinical practice guideline on nonrestorative treatments for carious lesions: A report from the American Dental Association. JADA. 2018;149(10):837–849.e19. - PubMed
    1. Castillo JL, Rivera S, Aparicio T, et al. The short-term effects of diammine silver fluoride on tooth sensitivity: a randomized controlled trial. J Dent Res. 2011;90:203–208. - PMC - PubMed
    1. Craig GG, Knight GM, McIntyre JM. Clinical evaluation of diamine silver fluoride/potassium iodide as a dentine desensitizing agent. A pilot study. Aust Dent J. 2012;57:308–311. - PubMed
    1. Tan HP, Lo EC, Dyson JE, et al. A randomized trial on root caries prevention in elders. J Dent Res. 2010;89:1086–1090. - PubMed
    1. Zhang W, McGrath C, Lo EC, et al. Silver diamine fluoride and education to prevent and arrest root caries among community-dwelling elders. Caries Res. 2013;47:284–290. - PubMed

Publication types